Stephen A. Hurly
2017
In 2017, Stephen A. Hurly earned a total compensation of $1.1M as President and Chief Executive Officer at Eleven Biotherapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Bonus | $116,802 |
|---|---|
| Option Awards | $521,527 |
| Salary | $425,000 |
| Other | $4,000 |
| Total | $1,067,329 |
Hurly received $521.5K in option awards, accounting for 49% of the total pay in 2017.
Hurly also received $116.8K in bonus, $425K in salary and $4K in other compensation.
Rankings
In 2017, Stephen A. Hurly's compensation ranked 8,678th out of 14,666 executives tracked by ExecPay. In other words, Hurly earned more than 40.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,678 out of 14,666 | 41st |
Division Manufacturing | 3,304 out of 5,772 | 43rd |
Major group Chemicals And Allied Products | 1,117 out of 2,075 | 46th |
Industry group Drugs | 888 out of 1,731 | 49th |
Industry Pharmaceutical Preparations | 695 out of 1,333 | 48th |
Source: SEC filing on April 30, 2018.
Hurly's colleagues
We found three more compensation records of executives who worked with Stephen A. Hurly at Eleven Biotherapeutics in 2017.